{"id":"W2309079920","doi":"10.3833/pdr.v2014i9.2063","title":"Roche to Buy InterMune for US$8.3 B to Gain Pirfenidone for Idiopathic Pulmonary Fibrosis","year":2014,"lang":"en","type":"article","venue":"PharmaDeals Review","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pirfenidone; Medicine; Franchise; Idiopathic pulmonary fibrosis; Asthma; Omalizumab; Internal medicine; Business; Business administration; Lung; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015939,0.0009920998,0.0005878015,0.001086823,0.0003627275,0.001287275,0.000653081,0.003093891,0.09892388],"category_scores_gemma":[0.001251573,0.0002486524,0.0007315212,0.000598411,0.0003588129,0.001247579,0.0006108484,0.002263648,0.06751117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006685389,"about_ca_system_score_gemma":0.001103321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001796392,"about_ca_topic_score_gemma":0.003650979,"domain_scores_codex":[0.9995159,0.00006643868,0.0000212415,0.00007296883,0.0002555687,0.00006790166],"domain_scores_gemma":[0.9994124,0.0001164242,0.00006609215,0.00002517649,0.0001715095,0.0002082624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003984029,0.0002292098,0.0002051537,0.001265297,0.00004160004,0.0006435866,0.00003338397,0.0001020607,0.005754207,0.005687973,0.4382179,0.5474213],"study_design_scores_gemma":[0.0001679779,0.0002253866,0.0003587424,0.000287976,0.00001290173,0.0008997417,0.00001033664,0.00003024764,0.0006897605,0.0004275905,0.9968818,0.000007470554],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.00223454,0.6296595,0.00198528,0.02636408,0.00960632,0.0004130268,0.0008859815,0.0007009719,0.3281502],"genre_scores_gemma":[0.0311942,0.347559,0.005582581,0.02692126,0.00584899,0.0003674513,0.00186087,0.000210605,0.5804551],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.09892388,"threshold_uncertainty_score":0.3309334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02739605113640022,"score_gpt":0.3444773393026677,"score_spread":0.3170812881662675,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}